UniProt O19712
MHC class II HLA-DQ-beta-1 (O19712)
MHC class II HLA-DQ-beta-1 (UniProt O19712): 24 experimental structures on GenesisL1, 4 ligands bound, 83 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- O19712
- Protein
- MHC class II HLA-DQ-beta-1
- Experimental structures
- 24
- Predicted models
- 0
- Ligands
- 4
- Pockets
- 83 · 9 records with a druggable one
Structures
24 records of O19712 in the MolNFT archive: 24 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 5KSU | Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution | x-ray diffraction | B, E | — | — |
| 5KSU | Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution | x-ray diffraction | B, E | — | — |
| 5KSV | Crystal structure of HLA-DQ2.5-CLIP2 | x-ray diffraction | B | — | 2 (best 0.54) |
| 5KSV | Crystal structure of HLA-DQ2.5-CLIP2 | x-ray diffraction | B | — | — |
| 6MFF | HLA-DQ2-glia-OMEGA1 | x-ray diffraction | C | — | — |
| 6MFG | HLA-DQ2-glia-ALPHA1 | x-ray diffraction | E, F | — | — |
| 6U3M | DQ2-P.fluor-alpha1a | x-ray diffraction | D, B | NAG, PO4 | 7 (best 0.52) |
| 6U3M | DQ2-P.FLUOR-ALPHA1A | x-ray diffraction | D, B | NAG, PO4 | — |
| 6U3N | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | x-ray diffraction | B | — | 6 (best 0.71) |
| 6U3N | LS2.8/3.15 - DQ2-P.FLUOR-ALPHA1A complex | x-ray diffraction | B | — | — |
| 6U3O | JR51 DQ2-p.aeru-alpha2a complex | x-ray diffraction | D, F | — | 9 (best 0.58) |
| 6U3O | JR51 DQ2-P.AERU-ALPHA2A complex | x-ray diffraction | D, F | — | — |
| 6XP6 | 3C11-DQ2-glia-a2 complex | x-ray diffraction | B, E | NAG, FUC | — |
| 6XP6 | 3C11-DQ2-glia-A2 complex | x-ray diffraction | B, E | NAG, FUC | — |
| 7SG0 | W316 TCR in complex with HLA-DQ2-omega1 | x-ray diffraction | B | NAG | 6 (best 0.71) |
| 7SG0 | W316 TCR in complex with HLA-DQ2-OMEGA1 | x-ray diffraction | B | NAG | — |
| 7SG1 | XPA5 TCR in complex with HLA-DQ2-alpha1 | x-ray diffraction | B, G | — | 13 (best 0.51) |
| 7SG1 | XPA5 TCR in complex with HLA-DQ2-ALPHA1 | x-ray diffraction | B, G | — | — |
| 7SG2 | XPA5 TCR in complex with HLA-DQ2-omega1 | x-ray diffraction | B, G | CA | — |
| 7SG2 | XPA5 TCR in complex with HLA-DQ2-OMEGA1 | x-ray diffraction | B, G | CA | — |
| 8W83 | HLA-DQ2.5-alpha1 gliadin peptide in complex with DQN0344AE02 | x-ray diffraction | D, H, L, P | — | 12 (best 0.78) |
| 8W84 | HLA-DQ2.5-alpha2 gliadin peptide in complex with DQN0344AE02 | x-ray diffraction | D | NAG | 5 (best 0.68) |
| 8W85 | HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01 | x-ray diffraction | D, H | — | 12 (best 0.67) |
| 8W86 | HLA-DQ2.5-B/C hordein peptide in complex with DQN0385AE02 | x-ray diffraction | D, H | — | 11 (best 0.49) |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.